toripalimab
Shanghai Junshi Bioscience,coherus
['lcsm,(-blcsm)', 'choice-01']
choice-01; another chemoio trial: points of interest = clear is benefit despite high crossover in standard arm. learning point = line matters. good sqcc data. #asco23 #lcsm 
Consultant Medical Oncologist, UK. Views are hypothesis generating discourse. Post COVID dabbling in garden.